Overview

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Status:
Terminated

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the multi-lineage hematopoietic chimerism for unrelated umbilical cord blood (UCB) grafts pooled from two to three cord blood units. Also to evaluate the toxicity, and antitumor responses of pooled unrelated UCB transplants.

Phase:

Phase 2

Details

Lead Sponsor:

Texas Oncology Cancer Center

Treatments:

Busulfan
Carmustine
Clofarabine
Cytarabine
Etoposide
Etoposide phosphate
Fludarabine
Fludarabine phosphate
Melphalan
Vidarabine